KAI-9531
K9531-3107
Phase 3 small_molecule active
Quick answer
KAI-9531 for Obesity is a Phase 3 program (small_molecule) at Kailera Therapeutics with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Kailera Therapeutics
- Indication
- Obesity
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active